U.S. Markets close in 2 hrs 54 mins

Free Pre-Market Technical Pulse on CF Industries and Three More Agricultural Chemicals Stocks

Stock Research Monitor: RKDA, IPI, and MBII

LONDON, UK / ACCESSWIRE / May 29, 2018 / If you want a free Stock Review on CF sign up now at www.wallstequities.com/registration. This morning, WallStEquities.com revisits the Agricultural Chemicals space, which produces much of agriculture's applied research, and maintains the database of agricultural, technical, and scientific knowledge. Under review this morning are the following equities: Arcadia Biosciences Inc. (NASDAQ: RKDA), CF Industries Holdings Inc. (NYSE: CF), Intrepid Potash Inc. (NYSE: IPI), and Marrone Bio Innovations Inc. (NASDAQ: MBII). All you have to do is sign up today for this free limited time offer by clicking the link below:

www.wallstequities.com/registration

Arcadia Biosciences

Last Friday, shares in Davis, California headquartered Arcadia Biosciences Inc. ended the session 2.16% lower at $9.98. The stock recorded a trading volume of 98,434 shares. The Company's shares have surged 98.41% over the previous three months. The stock is trading below its 200-day moving average by 0.20%. Furthermore, shares of Arcadia Biosciences, which develops and commercializes health and nutrition ingredient traits worldwide, have a Relative Strength Index (RSI) of 39.10.

On May 15th, 2018, Arcadia Biosciences announced that Albert D. Bolles, Ph.D., a leading consumer food industry executive, has joined its Board of Directors. Bolles is the former Executive Vice President, Chief Technology and Operations Officer of ConAgra Foods, where he led a technical organization including research, quality, innovation, and supply chain functions, with over 10,000 employees and 100 manufacturing facilities. Get the full research report on RKDA for free by clicking below at:

www.wallstequities.com/registration/?symbol=RKDA

CF Industries Holdings

Deerfield, Illinois headquartered CF Industries Holdings Inc.'s stock finished 0.60% higher at $41.66 with a total trading volume of 1.92 million shares. The Company's shares have gained 4.62% in the last month and 48.31% over the past year. The stock is trading above its 50-day and 200-day moving averages by 7.34% and 10.22%, respectively. Moreover, shares of CF Industries, which manufactures and distributes nitrogen fertilizers and other nitrogen products worldwide, have an RSI of 62.65.

On May 02nd, 2018, CF Industries announced the results for its Q1 ended March 31st, 2018. Net earnings attributable to common stockholders for Q1 2018 were $63 million, EBITDA was $302 million, and adjusted EBITDA was $296 million. As of March 31st, 2018, the Company had cash and cash equivalents of $936 million on the balance sheet.

On May 15th, 2018, research firm Stifel reiterated its ‘Hold' rating on the Company's stock with an increase of the target price from $37 a share to $43 a share. Download our actionable research report on CF at:

www.wallstequities.com/registration/?symbol=CF

Intrepid Potash

Shares in Denver, Colorado-based Intrepid Potash Inc. closed the day 1.47% lower at $4.69. The stock recorded a trading volume of 933,399 shares. The Company's shares have gained 23.42% over the previous three months and 98.73% over the past year. The stock is trading above its 50-day and 200-day moving averages by 13.27% and 19.40%, respectively. Moreover, shares of Intrepid Potash, which produces and sells potash and langbeinite products in the US and internationally, have an RSI of 57.31.

On May 09th, 2018, research firm Stephens upgraded the Company's stock rating from ‘Equal-Weight' to ‘Overweight'. Register for your free report coverage on IPI at:

www.wallstequities.com/registration/?symbol=IPI

Marrone Bio Innovations

Davis, California headquartered Marrone Bio Innovations Inc.'s shares recorded a trading volume of 300,813 shares last Friday. The stock closed 4.09% higher at $1.78. The Company's shares have advanced 4.71% in the past month, 56.14% in the previous three months, and 48.33% over the past year. The stock is trading 35.12% above its 200-day moving average. Additionally, shares of the Company, which provides bio-based pest management and plant health products primarily for agricultural and water markets in the US and internationally, have an RSI of 47.98.

On May 07th, 2018, Marrone Bio Innovations announced that Kevin Hammill has joined the Company as Chief Commercial Officer. Mr. Hammill brings over 25 years of leadership experience and broad commercial success in the crop protection, plant nutrition, and biotechnology industries. Get the free research report on MBII at:

www.wallstequities.com/registration/?symbol=MBII

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities